Home
Browse All Titles
Sign In
Browse All Titles
FITZPATRICK'S COLOR ATLAS AND SYNOPSIS OF CLINICAL DERMATOLOGY
Newer Chemotherapeutic Agents and Their ACDR
Table of Contents
Free Topics
About
Abscess, Folliculitis, Furuncle, and Carbuncle
Acanthosis Nigricans (AN)
ACDR-Related Necrosis
Acknowledgments
Acne Vulgaris (Common Acne) and Cystic Acne
Acquired Perforating Dermatoses
Cicatricial or Scarring Alopecia
Cutaneous Melanoma
Cutaneous Reactions to Arthropod Bites
Flowchart - Approach to the Patient with Angioedema (Without Urticaria)
Flowchart - Approach to the Patient with Urticaria/Angioedema
Hidradenitis Suppurativa
Preface
Pustular Eruptions
I. Disorders Presenting in the Skin and Mucous Membranes
1. Disorders of Sebaceous, Eccrine, and Apocrine Glands
Acne Vulgaris (Common Acne) and Cystic Acne
Chromhidrosis and Bromhidrosis
F - 1-1. Acne Vulgaris: Comedones
F - 1-10. Papulopustular Rosacea (Early Stage III)
F - 1-11. Rosacea (Stage III)
F - 1-12. Perioral Dermatitis
F - 1-13. Perioral Dermatitis
F - 1-14. Periorbital Dermatitis
F - 1-15. Miliaria Crystallina
F - 1-16. Chromhidrosis
F - 1-17. Hidradenitis Suppurativa
F - 1-18. Hidradenitis Suppurativa
F - 1-19. Hidradenitis Suppurativa
F - 1-2. 20-Year-Old Male
F - 1-20. Hidradenitis Suppurativa
F - 1-21. Fox Fordyce Disease
F - 1-3. Nodulocystic Acne
F - 1-4. Acne Pathogenesis
F - 1-5. Acne Conglobata
F - 1-6. Acne Conglobata on the Trunk
F - 1-7. Erythematous Rosacea (Stage I)
F - 1-8. Rosacea
F - 1-9. Rosacea (Stages II-III)
Fox Fordyce Disease
Hidradenitis Suppurativa
Hyperhidrosis
Miliaria
Periorificial Dermatitis
Rosacea
10. Photosensitivity, Photo-Induced Disorders, and Disorders by Ionizing Radiation
Actinic Keratosis
Acute Sun Damage (Sunburn)
Chondrodermatitis Nodularis Helicis
Dermatoheliosis ('Photoaging') - Chronic Photodamage
Drug-/Chemical-Induced Photosensitivity
Erythropoietic Protoporphyria
F - 10-1. Variations in Solar Exposure on Different Body Areas
F - 10-10. Polymorphic Light Eruption
F - 10-11. Solar Urticaria
F - 10-12. Porphyria Cutanea Tarda
F - 10-13. Porphyria Cutanea Tarda
F - 10-14. Porphyria Cutanea Tarda
F - 10-15. Porphyria Cutanea Tarda: Wood Light
F - 10-16. Variegate Porphyria
F - 10-17. Erythropoietic Protoporphyria
F - 10-18. Erythropoietic Protoporphyria
F - 10-19. Erythropoietic Protoporphyria, Chronic Skin Changes
F - 10-2. Acute Sunburn
F - 10-20. Dermatoheliosis
F - 10-21. Severe Dermatoheliosis on the Forearm of a 70-Year-Old Female Farmhand
F - 10-22. Dermatoheliosis: Solar Lentigines
F - 10-23. Dermatoheliosis: Solar Lentigines
F - 10-24. Chondrodermatitis Nodularis Helicis
F - 10-25. Radiation Dermatitis: Acute, Recall Phenomenon
F - 10-26. Radiation Dermatitis: Chronic
F - 10-27. Radiation Dermatitis: Chronic
F - 10-28. Radiation Dermatitis: Chronic
F - 10-29. Radiation Dermatitis: Chronic
F - 10-3. Phototoxic Drug-Induced Photosensitivity
F - 10-30. Radiation-Induced Squamous Cell Carcinoma
F - 10-4. Phytophotodermatitis (Plant + Light): Acute with Blisters
F - 10-5. Phytophotodermatitis
F - 10-6. Berloque Dermatitis
F - 10-7. Photoallergic Drug-Induced Photosensitivity
F - 10-8. Drug-Induced Photosensitivity: Chronic Actinic Dermatitis (Formerly Persistent Light Eruption)
F - 10-9. Polymorphic Light Eruption, Popular Variant
Metabolic Photosensitivitythe Porphyrias
Photoallergic Drug/Chemical-Induced Photosensitivity
Photo-Exacerbated Dermatoses
Phototoxic Drug-/Chemical-Induced Photosensitivity
Phytophotodermatitis (PPD)
Polymorphous Light Eruption (PMLE)
Porphyria Cutanea Tarda
Radiation Dermatitis - Skin Reactions to Ionizing Radiation
Skin Reactions to Sunlight
Solar Lentigo
Solar Urticaria
Systemic Phototoxic Dermatitis
T - 10-1. Simplified Classification of Skin Reactions to Sunlight
T - 10-2. Classification of Fitzpatrick's Skin Phototypes (SPT)
T - 10-3. Characteristics of Phototoxicity and Photoallergy
T - 10-4. Systemic Phototoxic Agents
T - 10-5. Topical Photoallergens
T - 10-6. Human Porphyrias: Specific Enzymes Affected by Mutations, Modes of Inheritance, Classification, and Major Types of Clinical Features
T - 10-7. Drugs Hazardous to Patients with Variegate and Acute Intermittent Porphyria
Topical Phototoxic Dermatitis
Variegate Porphyria
11. Precancerous Lesions and Cutaneous Carcinomas
Actinic Keratosis
Arsenical Keratoses
Basal Cell Carcinoma (BCC)
Basal Cell Nevus Syndrome (BCNS)
Cutaneous Horn
Epidermal Precancers and Cancers
F - 11-1. Erythematous and Brownish Macules and Papules with Coarse Adherent Scale Became Confluent on the Bald Scalp with Dermatoheliosis
F - 11-10. Squamous Cell Carcinoma (SCC): Invasive on the Lip
F - 11-11. Squamous Cell Carcinoma (SCC)
F - 11-12. Squamous Cell Carcinoma (SCC), Well Differentiated
F - 11-13. Squamous Cell Carcinoma (SCC), Advanced, Well Differentiated, on the Hand of a 65-Year-Old
F - 11-14. Squamous Cell Carcinoma (SCC), Undifferentiated
F - 11-15. Squamous Cell Carcinoma (SCC) (Carcinoma Cuniculatum) in a Patient with Peripheral Neuropathy Caused by Leprosy
F - 11-16. Squamous Cell Carcinomas (SCC) in a Renal Transplant Recipient on the Upper Thigh and Buttocks
F - 11-17. Keratoacanthoma Showing Different Stages of Evolution
F - 11-18. Basal Cell Carcinoma (BCC): Nodular Type
F - 11-19. Basal Cell Carcinoma (BCC): Nodular Type
F - 11-2. Actinic Keratosis, Close Up
F - 11-20. Basal Cell Carcinoma (BCC), Ulcerated: Rodent Ulcer
F - 11-21. A Large Rodent Ulcer in the Nuchal and Retroauricular Area Extending to the Temple
F - 11-22. Basal Cell Carcinoma (BCC): Sclerosing Type
F - 11-23. Basal Cell Carcinoma (BCC), Sclerosing, Nodular, and Ulcerating
F - 11-24. Superficial Basal Cell Carcinoma (BCC): Solitary Lesion and Multiple Lesions
F - 11-25. Superficial Basal Cell Carcinoma (BCC), Invasive
F - 11-26. Basal Cell Carcinoma (BCC), Pigmented
F - 11-27. Basal Cell Carcinoma (BCC): Predilection Sites
F - 11-28. Basal Cell Nevus Syndrome: Small Basal Cell Carcinomas (BCC)
F - 11-29. Basal Cell Nevus Syndrome: Palmar Pits
F - 11-3. Spreading Pigmented Actinic Keratosis (SPAK)
F - 11-30. Merkel Cell Carcinoma
F - 11-31. Merkel Cell Carcinoma
F - 11-4. Solar Keratoses and Invasive Squamous Cell Carcinoma (SCC)
F - 11-5. Cutaneous Horn (CH): Hypertrophic Actinic Keratosis
F - 11-6. Arsenical Keratoses
F - 11-7. Squamous Cell Carcinoma (SCC) in Situ: Bowen Disease
F - 11-8. Squamous Cell Carcinoma in Situ (SCCIS): Bowen Disease and Invasive SCC: Bowen Carcinoma
F - 11-9. Squamous Cell Carcinoma (SCC): Predilection Sites
Invasive Squamous Cell Carcinoma
Keratoacanthoma
Malignant Appendage Tumors
Merkel Cell Carcinoma
Squamous Cell Carcinoma in Situ
12. Melanoma Precursors and Primary Cutaneous Melanoma
Acral Lentiginous Melanoma (ALM)
Amelanotic Melanoma
Congenital Melanocytic Nevus (CMN)
Cutaneous Melanoma
Desmoplastic Melanoma (DM)
Dysplastic Melanocytic Nevus (DN)
F - 12-1. Dysplastic Nevi
F - 12-10. Lentigo Maligna Melanoma
F - 12-11. Mel
F - 12-12. Superficial Spreading Melanoma
F - 12-13. Superficial Spreading Melanoma, Radial Growth Phase
F - 12-14. Superficial Spreading Melanoma, Vertical Growth Phase
F - 12-15. Nodular Melanoma
F - 12-16. Nodular Melanoma
F - 12-17. Desmoplastic Melanoma
F - 12-18. Acral Lentiginous Melanoma
F - 12-19. Amelanotic Melanoma
F - 12-2. Dysplastic Nevi
F - 12-20. Metastatic Melanoma
F - 12-21. Metastatic Melanoma: Recurring in Excision Scar
F - 12-22. Universal Melanosis Caused by Metastatic Melanoma
F - 12-3. Superficial Spreading Melanoma: Arising Within a Dysplastic Nevus
F - 12-4. Congenital Nevomelanocytic Nevus
F - 12-5. A Giant Congenital Nevomelanocytic Nevus
F - 12-6. Melanoma: Arising in Small Cmn
F - 12-7. Melanoma in Situ: Lentigo Maligna
F - 12-8. Melanoma in Situ, Superficial Spreading Type
F - 12-9. Lentigo Maligna
Lentigo Maligna Melanoma (LMM)
Malignant Melanoma of the Mucosa
Management of Melanoma
Melanoma in Situ (MIS)
Metastatic Melanoma
Nodular Melanoma (NM)
Precursors of Cutaneous Melanoma
Prognosis of Melanoma
Staging of Melanoma
Superficial Spreading Melanoma (SSM)
T - 12-1. Comparative Features of Common Melanocytic Nevi (MN), Dysplastic Nevi (DN), and Superficial Spreading Melanoma (SSM)
T - 12-2. Risk Factors for the Development of Melanoma
T - 12-3. Four Major Types of Melanoma
T - 12-4. Melanoma TNM Classifications (AJCC 2017)
13. Pigmentary Disorders
13. Pigmentary Disorders
F - 13-1. Vitiligo: Face
F - 13-10. Hypermelanosis with Acne
F - 13-11. Postinflammatory Hyperpigmentation
F - 13-12. Postinflammatory Dermal Hyperpigmentation
F - 13-13. Melanodermatitis Toxica
F - 13-14. Pityriasis Versicolor
F - 13-15. Postinflammatory Hypomelanosis (Psoriasis)
F - 13-16. Postinflammatory Hypopigmentation
F - 13-17. Mottled Hypopigmentation, but Also Hyperpigmentation
F - 13-18. Pityriasis Alba
F - 13-2. Vitiligo: Knees
F - 13-3. Vitiligo: Predilection Sites
F - 13-4. Universal Vitiligo
F - 13-5. Vitiligo Repigmentation
F - 13-6. Vitiligo: Therapy-Induced Repigmentation
F - 13-7. Oculocutaneous Albinism
F - 13-8. Squamous Cell Carcinoma in an Albino from Tanzania
F - 13-9. Melasma
Hyperpigmentation - Pigmentary Changes Following Inflammation of the Skin
Hypopigmentation
Melasma
Oculocutaneous Albinism
T - 13-1. Classification of Albinism
Vitiligo
2. Eczema/Dermatitis
2. Eczema/Dermatitis
Acute Irritant Contact Dermatitis
Airborne ACD - Other Special Forms of ACD
Allergic Contact Dermatitis (ACD)
Allergic Contact Dermatitis Caused by Plants - Special Forms of ACD
Asteatotic Dermatitis
Atopic Dermatitis
Autosensitization Dermatitis
Chronic Irritant Contact Dermatitis
Contact Dermatitis
Dyshidrotic Eczematous Dermatitis
F - 2-1. Acute Irritant Contact Dermatitis Following Application of a Cream Containing Nonylvanillamid and Nicotinic Acid Butoxyethyl Ester Prescribed for Lower Back Pain
F - 2-10. Acute Allergic Phytodermatitis, Bullous
F - 2-11. Airborne Allergic Contact Dermatitis of the Face
F - 2-12. Atopic Dermatitis: Infantile
F - 2-13. Childhood Atopic Dermatitis
F - 2-14. Childhood Atopic Dermatitis
F - 2-15. Childhood Atopic Dermatitis
F - 2-16. Predilection Sites of Atopic Dermatitis
F - 2-17. Adult Atopic Dermatitis
F - 2-18. Lichen Simplex Chronicus
F - 2-19. Prurigo Nodularis
F - 2-2. Acute Irritant Contact Dermatitis on the Hand Resulting from an Industrial Solvent
F - 2-20. Dyshidrotic Eczematous Dermatitis
F - 2-21. Nummular Eczema
F - 2-22. Autosensitization Dermatitis ('Id' Reaction): Dermatophytid
F - 2-23. Seborrheic Dermatitis of Face: Adult Type
F - 2-24. Seborrheic Dermatitis: Infantile Type
F - 2-25. Asteatotic Dermatitis
F - 2-3. Early Chronic Irritant Contact Dermatitis in a Housewife
F - 2-4. Chronic Irritant Dermatitis with Acute Exacerbation in a Housewife
F - 2-5. Acute Allergic Contact Dermatitis on the Lips Caused by Lipstick
F - 2-6. Allergic Contact Dermatitis of Hands: Chromates
F - 2-7. Allergic Contact Dermatitis Resulting from Nickel, Subacute
F - 2-8. Allergic Phytodermatitis of Leg: Poison Ivy
F - 2-9. Allergic Phytodermatitis of the Face: Poison Ivy
Irritant Contact Dermatitis (ICD)
Lichen Simplex Chronicus (LSC)
Nummular Eczema
Prurigo Nodularis (PN)
Seborrheic Dermatitis
Special Forms of ICD
Suggested Algorithm of Ad Management
Systemic ACD - Other Special Forms of ACD
T - 2-1. Common Irritants
T - 2-2. Most Common Allergens
T - 2-3. Differences between Irritant and Allergic Contact Dermatitis
3. Psoriasis, Psoriasiform, and Pityriasiform Dermatoses
F - 3-1. Psoriasis Vulgaris
F - 3-10. Psoriasis of the Fingernails
F - 3-11. Palmar Pustulosis
F - 3-12. Generalized Acute Pustular Psoriasis (Von Zumbusch)
F - 3-13. Annular Pustular Psoriasis
F - 3-14. A. Psoriatic Arthritis
F - 3-15. Pityriasis Rubra Pilaris (Type 1, Classic Adult)
F - 3-16. Pityriasis Rubra Pilaris (Type 1, Classic Adult)
F - 3-17. Pityriasis Rubra Pilaris (Type 4)
F - 3-18. Pityriasis Rubra Pilaris on Palms
F - 3-19. Pityriasis Rosea
F - 3-2. Psoriasis Vulgaris: Buttocks (Guttate Type)
F - 3-20. Pityriasis Rosea
F - 3-21. Digitate Dermatosis (Small-Plaque Parapsoriasis)
F - 3-22. Large-Plaque Parapsoriasis (Parapsoriasis En Plaques)
F - 3-23. Pityriasis Lichenoides et Varioliformis Acuta (Pleva)
F - 3-3. Psoriasis Vulgaris: Elbow
F - 3-4. Psoriasis Vulgaris: Chronic Stable Type
F - 3-5. Predilection Sites of Psoriasis
F - 3-6. Psoriasis, Palmar Involvement
F - 3-7. Psoriasis of the Scalp
F - 3-8. Psoriasis, Facial Involvement
F - 3-9. Psoriasis Vulgaris: Inverse Pattern
Generalized Acute Pustular Psoriasis (Von Zumbusch)
Management of Psoriasis
Palmoplantar Pustulosis
Parapsoriasis En Plaques (PP)
Pityriasis Lichenoides (Acute and Chronic) (Pl)
Pityriasis Rosea
Pityriasis Rubra Pilaris (PRP)
Psoriasis
Psoriasis Vulgaris
Psoriatic Arthritis
Psoriatic Erythroderma
Pustular Psoriasis
4. Ichthyoses
4. Ichthyoses
Acquired Ichthyoses
Collodion Baby - Ichthyosis in the Newborn
Epidermolytic Ichthyosis
F - 4-1. Ichthyosis Vulgaris: Back
F - 4-10. Epidermolytic Hyperkeratosis: Arms and Hands
F - 4-11. Distribution of Epidermolytic Hyperkeratosis
F - 4-12. Ichthyosis in the Newborn
F - 4-13. Harlequin Fetus
F - 4-14. Erythrokeratodermia Variabilis
F - 4-15. Keratitis-Ichthyosis-Deafness (KID) Syndrome
F - 4-16. Netherton Syndrome
F - 4-17. Plantar Keratoderma, Diffuse Type
F - 4-18. Punctate Palmar Keratoderma
F - 4-19. Striate Palmar Keratoderma
F - 4-2. Ichthyosis Vulgaris: Legs
F - 4-3. Distribution of Ichthyosis Vulgaris
F - 4-4. Ichthyosis Vulgaris
F - 4-5. X-Linked Ichthyosis: Trunk, Buttocks, and Arms
F - 4-6. Distribution of X-Linked Ichthyosis
F - 4-7. Lamellar Ichthyosis
F - 4-8. Lamellar Ichthyosis
F - 4-9. Distribution of Lamellar Ichthyosis
Harlequin Fetus
Ichthyosis Vulgaris
Inherited Keratodermas of Palms and Soles
Lamellar Ichthyosis
Syndromic Ichthyoses
X-Linked Recessive Ichthyosis
5. Miscellaneous Epidermal Disorders
Acanthosis Nigricans (AN)
Darier Disease (DD)
Disseminated Superficial Actinic Porokeratosis (DSAP)
F - 5-1. Acanthosis Nigricans
F - 5-2. Malignant Acanthosis Nigricans
F - 5-3. Darier Disease: Chest
F - 5-4. Darier Disease: Forehead
F - 5-5. Grover Disease
F - 5-6. Hailey-Hailey Disease
F - 5-7. Disseminated Superficial Actinic Porokeratosis
Grover Disease (GD)
Hailey-Hailey Disease (Familial Benign Pemphigus)
Other Porokeratoses
6. Genetic and Acquired Bullous Diseases
6. Genetic and Acquired Bullous Diseases
Bullous Pemphigoid (BP)
Dermatitis Herpetiformis (DH)
Epidermolysis Bullosa Acquisita (EBA)
F - 6-1. Schematic of the Components of Dermal-Epidermal Basement Membrane and Levels of Dermal-Epidermal Separation in Hereditary and Autoimmune Bullous Diseases with Dermal-Epidermal Cleavage Discussed in This Atlas
F - 6-10. Pemphigus Vulgaris
F - 6-11. Pemphigus Vegetans
F - 6-12. Pemphigus Foliaceus
F - 6-13. Bullous Pemphigoid
F - 6-14. Bullous Pemphigoid
F - 6-15. Mucous Membrane Pemphigoid
F - 6-16. Pemphigoid Gestationis
F - 6-17. Dermatitis Herpetiformis
F - 6-18. Dermatitis Herpetiformis
F - 6-19. Dermatitis Herpetiformis
F - 6-2. Generalized EBS (Koebner)
F - 6-20. Linear Iga Dermatosis
F - 6-21. Linear Iga Dermatosis (Chronic, Bullous Disease of Childhood)
F - 6-22. Epidermolysis Bullosa Acquisita
F - 6-3. Localized EBS
F - 6-4. Junctional Epidermolysis Bullosa, Severe Type
F - 6-5. Junctional Epidermolysis Bullosa, Intermediate Type
F - 6-6. Generalized Recessive Dystrophic Epidermolysis Bullosa (RDEB)
F - 6-7. Generalized Recessive Dystrophic Epidermolysis Bullosa (RDEB)
F - 6-8. Pemphigus Vulgaris
F - 6-9. Pemphigus Vulgaris
Hereditary Epidermolysis Bullosa (EB)
Linear Iga Dermatosis (LAD)
Mucous Membrane Pemphigoid
Pemphigoid Gestationis (PG)
Pemphigus
T - 6-1. Classification of Epidermolysis Bullos
T - 6-2. Pemphigus Subtypes and Variants
T - 6-3. Differential Diagnosis of Important Acquired Bullous Diseases
7. Neutrophil-Mediated Diseases
Bowel-Associated Dermatosis-Arthritis Syndrome
Erythema Nodosum (EN) Syndrome
F - 7-1. Pyoderma Gangrenosum
F - 7-10. Pancreatic Panniculitis
F - 7-11. Perniosis (Chilblains) Erythematous to Slightly Violaceous Swellings on the Distal Digits and Palm
F - 7-2. Pyoderma Gangrenosum
F - 7-3. Pyoderma Gangrenosum
F - 7-4. Pyoderma Gangrenosum: Chronic Type
F - 7-5. Pyoderma Gangrenosum: Chronic Type
F - 7-6. Sweet Syndrome
F - 7-7. Sweet Syndrome
F - 7-8. Granuloma Faciale: Classic Presentation
F - 7-9. Erythema Nodosum
Granuloma Faciale (GF)
Other Panniculitides
Perniosis (Chilblains)
Pyoderma Gangrenosum (PG)
Sweet Syndrome (SS)
T - 7-1. Reported Etiologies of Erythema Nodosum
T - 7-2. Summary of Different Types of Panniculitis
8. The Acutely Ill and Hospitalized Patient
Exfoliative Erythroderma
F - 8-1. Exfoliative Dermatitis: Psoriasis
F - 8-2. Exfoliative Dermatitis: Drug Induced
F - 8-3. Exfoliative Dermatitis: Cutaneous T-Cell Lymphoma
F - 8-4. Generalized Fixed Drug Eruption: Tetracycline
F - 8-5. Generalized Rash with Fever: Measles
F - 8-6. Generalized Purpura, Necrosis, and Fever: DIC
F - 8-7. TEN, Exanthematic Presentation
F - 8-8. TEN, Exanthematic Presentation
F - 8-9. TEN, Nonexanthematic Diffuse Presentation
Rashes in the Acutely Ill Febrile Patient (ICD-10 Codes Based on Etiology)
Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
T - 8-1. The Most Commonly Implicated Drugs in Exfoliative Dermatitis
T - 8-2. Generalized Eruptions in the Acutely Ill Patient: Diagnosis According to Type of Lesion
T - 8-3. Medications and the Risk of Toxic Epidermal Necrolysis
T - 8-4. Scorten: A Prognostic Scoring System for Patients with Epidermal Necrolysis
9. Benign Neoplasms and Hyperplasias
Acquired Melanocytic Nevi - Disorders of Melanocytes
Angiokeratoma
Becker Nevus
Benign Dermal and Subcutaneous Neoplasms and Hyperplasias - Lipoma
Blue Nevus
Cherry Angioma
Congenital Dermal Melanocytosis
Cylindroma
Dermatofibroma
Digital Myxoid Cyst
Epidermal Inclusion Cyst
Epidermal Inclusion Cyst - Miscellaneous Cysts and Pseudocysts
Epidermal Nevus
F - 9-1. Multiple MN on the Shoulder of a 32-Year-Old Female
F - 9-10. Congenital Dermal Melanocytosis
F - 9-11. Congenital Dermal Melanocytosis
F - 9-12. Nevus of Ota
F - 9-13. Hemangioma of Infancy
F - 9-14. Hemangioma of Infancy
F - 9-15. Hemangioma of Infancy
F - 9-16. Hemangioma of Infancy, Deep Lesion
F - 9-17. Pyogenic Granuloma
F - 9-18. Glomus Tumor
F - 9-19. Port-Wine Stain
F - 9-2. (A-D) Junctional MN
F - 9-20. Port-Wine Stain
F - 9-21. Spider Nevus
F - 9-22. Venous Lake
F - 9-23. Cherry Angiomas
F - 9-24. Angiokeratoma: Solitary
F - 9-25. Angiokeratoma of Fordyce
F - 9-26. Angiokeratoma Corporis Diffusum (Fabry Disease)
F - 9-27. Lymphatic Malformation (Lymphangioma)
F - 9-28. Capillary-Venous Malformation in an Infant
F - 9-29. Capillary-Venous Malformation
F - 9-3. Compound MN
F - 9-30. Blue Rubber Bleb Nevus
F - 9-31. Epidermoid Cyst
F - 9-32. Trichilemmal Cyst
F - 9-33. Epidermal Inclusion Cyst
F - 9-34. Milia
F - 9-35. Digital Myxoid Cyst
F - 9-36. Seborrheic Keratosis, Solitary
F - 9-37. Seborrheic Keratoses (Dermatosis Papulosa Nigra)
F - 9-38. Seborrheic Keratosis
F - 9-39. Seborrheic Keratoses
F - 9-4. Dermal Melanocytic MN
F - 9-40. A and B Becker Nevus
F - 9-41. Trichoepitheliomas
F - 9-42. Syringomas
F - 9-43. Cylindroma
F - 9-44. Sebaceous Hyperplasia
F - 9-45. Nevus Sebaceous
F - 9-46. Epidermal Nevus
F - 9-47. Lipoma
F - 9-48. Dermatofibroma
F - 9-49. Hypertrophic Scar
F - 9-5. Halo Melanocytic MN on the Back of a 22-Year-Old Female
F - 9-50. Keloids
F - 9-51. Keloids
F - 9-52. Infantile Digital Fibromatosis
F - 9-53. Skin Tags
F - 9-6. Blue Nevus
F - 9-7. Blue Nevus and Cellular Blue Nevus
F - 9-8. Nevus Spilus
F - 9-9. Spitz Nevus
Glomus Tumor
Halo Melanocytic Nevus
Hemangioma of Infancy (Hi) - Vascular Tumors
Hypertrophic Scars and Keloids
Infantile Digital Fibromatosis
Lymphangioma - Lymphatic Malformation
Milium
Nevus of Ota
Nevus Sebaceous
Nevus Spilus
Port-Wine Stain (Pws) - Capillary Malformations
Pyogenic Granuloma
Sebaceous Hyperplasia
Seborrheic Keratosis - Miscellaneous Benign Neoplasms and Hyperplasias
Skin Tag
Spider Angioma
Spitz Nevus
Syringoma
T - 9-1. Classification of Vascular Anomalies
T - 9-2. Distinguishing Features of Vascular Tumors (Hemangiomas) and Vascular Malformations
Trichilemmal Cyst
Trichoepithelioma
Vascular Malformations
Vascular Tumors and Malformations
Venous Lake
Venous Malformations
II. Dermatology and Internal Medicine
14. The Skin in Immune, Autoimmune, Autoinflammatory, and Rheumatic Disorders
Behcet Disease
Chilblain Lupus
Chronic Cutaneous Lupus Erythematosus (CCLE)
Chronic Lupus Panniculitis (CLP)
Cryopyrinopathies (CAPS)
Dermatomyositis
Erythema Multiforme (EM) Syndrome
F - 14-1. Acute Urticaria
F - 14-10. Erythema Multiforme: Minor
F - 14-11. Erythema Multiforme: Major
F - 14-12. Erythema Multiforme: Major
F - 14-13. Erythema Multiforme
F - 14-14. Lichen Planus
F - 14-15. Hypertrophic Lichen Planus
F - 14-16. Disseminated Lichen Planus
F - 14-17. Lichen Planus
F - 14-18. Behcet Disease
F - 14-19. Behcet Disease: Genital Ulcers
F - 14-2. Chronic Urticaria
F - 14-20. Behcet Disease
F - 14-21. Revised International Criteria for Behcet Disease
F - 14-22. Dermatomyositis
F - 14-23. Dermatomyositis
F - 14-24. Dermatomyositis, Juvenile Onset, Poikiloderma
F - 14-25. Dermatomyositis
F - 14-26. The Spectrum of Lupus Erythematosus, as Envisaged by the Late Dr
F - 14-27. Acute Systemic Lupus Erythematosus
F - 14-28. Acute SLE
F - 14-29. Predilection Sites
F - 14-3. Acute Urticaria and Angioedema
F - 14-30. Subacute Cutaneous Lupus Erythematosus
F - 14-31. Chronic Cutaneous Lupus Erythematosus
F - 14-32. Chronic Cutaneous Lupus Erythematosus: Scarring
F - 14-33. Chronic Cutaneous Lupus Erythematosus
F - 14-34. Chronic Cutaneous Lupus Erythematosus: Hyperpigmentation
F - 14-35. Lupus Panniculitis
F - 14-36. Symptomatic Livedo Reticularis
F - 14-37. Raynaud Phenomenon
F - 14-38. Raynaud Phenomenon: Acral Gangrene
F - 14-39. Scleroderma (lSSc): Acrosclerosis
F - 14-4. Urticaria: Dermographism
F - 14-40. Scleroderma (lSSc): Acrosclerosis
F - 14-41. Scleroderma (dSSc)
F - 14-42. Scleroderma: Crest Syndrome
F - 14-43. Morphea
F - 14-44. Morphea
F - 14-45. Linear Morphea
F - 14-46. Linear Morphea, 'En Coup De Sabre'
F - 14-47. Macular Form of Morphea
F - 14-48. Pansclerotic Morphea
F - 14-49. Lichen Sclerosus et Atrophicus
F - 14-5. Cholinergic Urticaria
F - 14-50. Classification Scheme for the Vasculitides
F - 14-51. Hypersensitivity Vasculitis
F - 14-52. 42 Year Old Man with Purpura of the Leg and Abdomen Who Also Had Kidney Impairment and Blood in His Urine
F - 14-53. Polyarteritis Nodosa
F - 14-54. Granulomatosis with Polyangitis (Formerly Wegener Granulomatosis)
F - 14-55. GPA
F - 14-56. GPA
F - 14-57. Giant Cell Arteritis
F - 14-58. Urticarial Vasculitis
F - 14-59. Nodular Vasculitis
F - 14-6. Hereditary Angioedema
F - 14-60. Pigmented Purpuric Dermatosis:
F - 14-61. Kawasaki Disease
F - 14-62. Kawasaki Disease
F - 14-63. Kawasaki Disease
F - 14-64. Reactive Arthritis: Keratoderma Blennorrhagicum
F - 14-65. Reactive Arthritis: Balanitis Circinata
F - 14-66. Sarcoidosis
F - 14-67. Sarcoidosis
F - 14-68. Sarcoidosis
F - 14-69. Sarcoidosis in Scars
F - 14-7. Approach to the Patient with Urticaria/Angioedema
F - 14-70. Granuloma Annulare
F - 14-71. Systemic Al Amyloidosis
F - 14-72. Systemic Al Amyloidosis: 'Pinch Purpura'
F - 14-73. Systemic Al Amyloidosis: Macroglossia
F - 14-74. Localized Cutaneous Amyloidosis
F - 14-75. Macular Amyloidosis
F - 14-8. Approach to the Patient with Angioedema (Without Urticaria)
F - 14-9. Erythema Multiforme
Giant Cell Arteritis
Granuloma Annulare (GA)
Granulomatosis with Polyangitis (GPA)
Henochschonlein Purpura
Hypersensitivity Vasculitis (HV)
Kawasaki Disease (KD)
Lichen Planus (LP)
Lichen Sclerosus ET Atrophicus (LSA)
Livedo Reticularis (LR)
Localized Cutaneous Amyloidosis
Lupus Erythematosus (LE)
Morphea
Nodular Vasculitis
Pigmented Purpuric Dermatoses (PPD)
Polyarteritis Nodosa (PAN)
Raynaud Phenomenon (RP)
Reactive Arthritis (RA) (Formerly Reiter Syndrome)
Sarcoidosis
Scleroderma
Scleroderma-Like Conditions
Subacute Cutaneous Lupus Erythematosus (SCLE)
Systemic AA Amyloidosis
Systemic Al Amyloidosis
Systemic Lupus Erythematosus (SLE)
T - 14-1. Etiology and Classification of Urticaria/Angioedema
T - 14-2. Comprehensive Classification of Idiopathic Inflammatory Dermatomyopathies
T - 14-3. Abbreviated Gilliam Classification of Skin Lesions of LE
T - 14-4. Pathogenic Autoantibodies in Systemic Lupus Erythematosus
T - 14-5. Systemic Lupus International Collaborating Clinics (SLICC) Criteria
T - 14-6. Disorders Associated with Symptomatic Livedo Reticularis
T - 14-7. Causes or Disorders Associated with Secondary Raynaud Phenomenon
Urticaria and Angioedema
Urticarial Vasculitis
Vasculitis
15. Endocrine, Metabolic, and Nutritional Diseases
'Diabetic Foot' and Diabetic Neuropathy
Acquired Zinc Deficiency and Acrodermatitis Enteropathica
Addison Disease
Cholestasis of Pregnancy (CP)
Cushing Syndrome and Hypercorticism
Diabetic Bullae
Diabetic Dermopathy
Eruptive Xanthoma
F - 15-1. Diabetic Bulla
F - 15-10. Tendinous Xanthoma
F - 15-11. Tuberous Xanthoma
F - 15-12. Papular Eruptive Xanthomas
F - 15-13. Xanthoma Striatum Palmare
F - 15-14. Plane Xanthoma
F - 15-15. Scurvy
F - 15-16. Acquired Zinc Deficiency
F - 15-17. Acrodermatitis Enteropathica
F - 15-18. Pellagra
F - 15-19. Acute Gouty Arthritis
F - 15-2. Diabetic, Neuropathic Ulcer on the Sole
F - 15-20. Striae Distensae in a Pregnant Woman (36 Weeks of Gestation)
F - 15-21. Algorithm of Approach to a Pregnant Patient with Pruritus
F - 15-22. Polymorphic Eruption of Pregnancy [previously Called Pruritic Urticarial Papules and Plaques of Pregnancy (Puppp)]
F - 15-3. Diabetic Dermopathy
F - 15-4. Necrobiosis Lipoidica Diabeticorum
F - 15-5. Cushing Syndrome
F - 15-6. Graves Disease
F - 15-7. Myxedema
F - 15-8. Addison Disease
F - 15-9. Xanthelasma
Gout
Graves Disease and Hyperthyroidism
Hypothyroidism and Myxedema
Necrobiosis Lipoidica
Normolipemic Plane Xanthoma
Pellagra
Pemphigoid Gestationis (PEG)
Polymorphic Eruption of Pregnancy (PEP)
Prurigo of Pregnancy and Atopic Eruption of Pregnancy (AEP)
Pustular Psoriasis in Pregnancy
Scurvy
Skin Diseases Associated with Diabetes Mellitus
Skin Diseases in Pregnancy
Skin Manifestations of Obesity
T - 15-1. Classification of Genetic Hyperlipidemias
T - 15-2. Clinical Presentations of Xanthomas
Xanthelasma
Xanthoma Striatum Palmare
Xanthoma Tendineum
Xanthoma Tuberosum
Xanthomas - Metabolic and Nutritional Conditions
16. Genetic Diseases
F - 16-1. Pseudoxanthoma Elasticum
F - 16-10. Lisch Nodules are Visible Only by Slit-Lamp Examination and Appear as 'Glossy' Transient Dome-Shaped Yellow to Brown Papules of Up to 2 mm
F - 16-11. Hereditary Hemorrhagic Telangiectasia
F - 16-2. Tuberous Sclerosis: Ash-Leaflet Hypopigmented Macules
F - 16-3. Tuberous Sclerosis: 'Confetti' Macules
F - 16-4. Tuberous Sclerosis: Angiofibromas
F - 16-5. Tuberous Sclerosis
F - 16-6. Neurofibromatosis (NF1)
F - 16-7. Neurofibromatosis (NF1)
F - 16-8. Neurofibromatosis (NF1)
F - 16-9. Neurofibromatosis (NF1)
Hereditary Hemorrhagic Telangiectasia
Neurofibromatosis (NF)
Pseudoxanthoma Elasticum
Tuberous Sclerosis (TS)
17. Skin Signs of Vascular Insufficiency
Atherosclerosis, Arterial Insufficiency, and Atheroembolization
Chronic Lymphatic Insufficiency
Chronic Venous Insufficiency (CVI)
F - 17-1. Atherosclerosis Obliterans, Early
F - 17-10. Chronic Venous Insufficiency and Lipodermatosclerosis
F - 17-11. Venous Insufficiency
F - 17-12. Squamous Cell Carcinoma in Chronic Venous Ulcer
F - 17-13. Chronic Arterial Insufficiency with a Sharply Defined, 'Punched Out' Ulcer with Irregular Outlines
F - 17-14. Chronic Arterial and Venous Insufficiency, 'Combined' Arterial and Venous Ulcers
F - 17-15. Livedoid Vasculitis
F - 17-16. Chronic Lymphatic Insufficiency: Lymphedema
F - 17-17. Pressure Ulcer, Stage III
F - 17-18. Pressure Ulcer, Stage IV on the Heel
F - 17-2. Atherosclerosis Obliterans
F - 17-3. Atheroembolism after Angiography
F - 17-4. Atheroembolism with Cutaneous Infarction
F - 17-5. Thromboangiitis Obliterans
F - 17-6. Superficial Phlebitis and Deep Venous Thrombosis
F - 17-7. Varicose Veins
F - 17-8. Stasis Dermatitis in CVI
F - 17-9. Chronic Venous Insufficiency
Livedoid Vasculitis (LV)
Most Common Leg/Foot Ulcers
Pressure Ulcers
T - 17-1. Differential Diagnosis of Three Major Types of Leg Ulcers
Thromboangiitis Obliterans (to)
Thrombophlebitis and Deep Venous Thrombosis
18. Skin Signs of Renal Insufficiency
Acquired Perforating Dermatoses
Calciphylaxis
Classification of Skin Changes
F - 18-1. Calciphylaxis
F - 18-2. Calciphylaxis, Extensive
F - 18-3. Nephrogenic Fibrosing Dermopathy
F - 18-4. Acquired Perforating Dermatosis in a Patient Undergoing Hemodialysis
Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (Nsf)
19. Skin Signs of Systemic Cancers
Classification of Skin Signs of Systemic Cancer
Cowden Syndrome (Multiple Hamartoma Syndrome)
Extramammary Paget Disease
F - 19-1. Metastatic Cancer to the Skin: Bronchogenic Cancer
F - 19-10. Extramammary Paget Disease
F - 19-11. Cowden Syndrome
F - 19-12. Muir-Torre Syndrome
F - 19-13. Peutz-Jeghers Syndrome
F - 19-14. Glucagonoma Syndrome: Migratory Necrolytic Erythema
F - 19-15. Glucagonoma Syndrome: Migratory Necrolytic Erythema
F - 19-16. Glucagonoma Syndrome
F - 19-17. Paraneoplastic Pemphigus
F - 19-2. Metastatic Cancer to the Skin
F - 19-3. Metastatic Cancer to the Skin
F - 19-4. Metastatic Cancer of the Skin: Inflammatory Breast Cancer (Carcinoma Erysipelatodes)
F - 19-5. Metastatic Ovarian Cancer
F - 19-6. Mesothelioma
F - 19-7. Metastatic Breast Cancer: Cancer En Cuirasse
F - 19-8. Mammary Paget Disease
F - 19-9. Mammary Paget Disease
Glucagonoma Syndrome
Malignant Acanthosis Nigricans
Mammary Paget Disease
Metastatic Cancer to the Skin
Mucocutaneous Signs of Systemic Cancers
Muir-Torre Syndrome
Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS)
Peutz-Jeghers Syndrome
20. Skin Signs of Hematologic Disease
Cryoglobulinemia
Disseminated Intravascular Coagulation
F - 20-1. Thrombocytopenic Purpura
F - 20-10. Leukemia Cutis
F - 20-11. Leukemia Cutis
F - 20-12. Leukemia Cutis: Chloroma
F - 20-13. Langerhans Cell Histiocytosis: Eosinophilic Granuloma
F - 20-14. Langerhans Cell Histiocytosis
F - 20-15. Langerhans Cell Histiocytosis
F - 20-16. Langerhans Cell Histiocytosis: Letterer-Siwe Disease in an Adult
F - 20-17. Mastocytosis: Solitary Mastocytoma (NCM)
F - 20-18. Mastocytosis: Generalized (PPCM)
F - 20-19. Mastocytosis: Urticaria Pigmentosa (UP)
F - 20-2. Thrombocytopenic Purpura
F - 20-20. Mastocytosis: Telangiectasia Macularis Eruptiva Perstans (TMEP)
F - 20-21. Mastocytosis: Diffuse Cutaneous Mastocytosis (DCM)
F - 20-3. Disseminated Intravascular Coagulation: Purpura Fulminans
F - 20-4. Extensive Cutaneous Infarction with Hemorrhage Involving the Entire Leg
F - 20-5. Disseminated Intravascular Coagulation: Purpura Fulminans
F - 20-6. Cryoglobulinemia: Monoclonal (Type I)
F - 20-7. Cryoglobulinemia: Mixed (Type II)
F - 20-8. Cryoglobulinemia: Polyclonal (Type III)
F - 20-9. Leukemia Cutis
Langerhans Cell Histiocytosis
Leukemia Cutis
Mastocytosis Syndromes
T - 20-1. Revised Classification of Histiocytoses
T - 20-2. Classification of LCH and Historical Clinical Syndromes
T - 20-3. Revised WHO Classification of Mastocytosis
T - 20-4. Clinical Features of Cutaneous Mastocytosis (CM)
Thrombocytopenic Purpura
21. Cutaneous Lymphomas and Sarcoma
21. Cutaneous Lymphomas and Sarcoma
Adult T-Cell Leukemia/Lymphoma
Angiosarcoma
Atypical Fibroxanthoma (AFX)
Cutaneous Anaplastic Large Cell Lymphomas (CALCLs)
Cutaneous B-Cell Lymphoma
Cutaneous T-Cell Lymphoma
Dermatofibrosarcoma Protuberans (DFSP)
F - 21-1. Adult T-Cell Leukemia/Lymphoma
F - 21-10. Folliculotropic MF
F - 21-11. Pagetoid Reticulosis
F - 21-12. Granulomatous Slack Skin
F - 21-13. Lymphomatoid Papulosis
F - 21-14. Anaplastic Large Cell Lymphoma
F - 21-15. Cutaneous B-Cell Lymphoma
F - 21-16. Classic Kaposi Sarcoma
F - 21-17. HIV/AIDS-Associated Kaposi Sarcoma
F - 21-18. Classic Kaposi Sarcoma of the Feet
F - 21-19. Classic Kaposi Sarcoma
F - 21-2. Adult T-Cell Leukemia/Lymphoma
F - 21-20. HIV/AIDS-Associated Kaposi Sarcoma
F - 21-21. Angiosarcoma
F - 21-22. Dermatofibrosarcoma Protuberans
F - 21-23. Atypical Fibroxanthoma
F - 21-3. Mycosis Fungoides
F - 21-4. Mycosis Fungoides: Patches/Plaque Stage
F - 21-5. Mycosis Fungoides
F - 21-6. Mycosis Fungoides: Tumor Stage
F - 21-7. Mycosis Fungoides: Tumors
F - 21-8. Mycosis Fungoides: Leonine Facies
F - 21-9. Mycosis Fungoides: Poikilodermatous Lesions
Kaposi Sarcoma (KS)
Lymphomatoid Papulosis
Mycosis Fungoides (MF)
Mycosis Fungoides Variants
Sezary Syndrome
T - 21-1. WHO-EORTC Classification for Primary Cutaneous Lymhoma
T - 21-2. Patient Evaluation in MF
T - 21-3. TNM Staging of Mycosis Fungoides
22. Skin Diseases in Solid Organ and Bone Marrow Transplantation
22. Skin Diseases in Solid Organ and Bone Marrow Transplantation
Acute Cutaneous GVHD
Chronic Cutaneous GVHD
F - 22-1. Timeline of Common Infections after Transplantation
F - 22-2. Acute Cutaneous GVHD
F - 22-3. Acute Cutaneous GVHD Involving the Trunk
F - 22-4. Acute Cutaneous GVHD, Remitting
F - 22-5. Acute GVHR, TEN-Like
F - 22-6. Chronic Cutaneous GVHD, Lichen Planus-Like
F - 22-7. Chronic Cutaneous GVHD, Sclerodermoid
Graft-Versus-Host Disease (GVHD)
Skin Cancers Associated with Solid Organ Transplantation
T - 22-1. Clinical Staging of Acute Cutaneous GVHD
T - 22-2. NIH Consensus Scoring of Chronic Cutaneous GVHD
23. Adverse Cutaneous Drug Reactions
ACDR-Related Necrosis
ACDR-Related to Chemotherapy
Adverse Cutaneous Drug Reactions
Drug Hypersensitivity Syndrome
Drug-Induced Acute Urticaria, Angioedema, Edema, and Anaphylaxis
Drug-Induced Pigmentation
Exanthematous Drug Reactions
F - 23-1. Exanthematous Drug Eruption
F - 23-10. Drug-Induced Pigmentation: Minocycline
F - 23-11. Pseudoporphyria: Nonsteroidal Anti-Inflammatory Agents
F - 23-12. ACDR-Related Cutaneous Necrosis: Warfarin
F - 23-13. ACDR-Related Cutaneous Necrosis: Heparin
F - 23-14. ACDR-Related Cutaneous Necrosis: Interferon-
F - 23-15. ACDR-Related Cutaneous Necrosis: Ergotamine
F - 23-16. ACDR-Related Necrosis Following Intramuscular Injection
F - 23-17. ACDR-Related Necrosis with Hemorrhagic Blistering after an Overdose of Barbiturates
F - 23-18. ACDR to Egfr Antagonists: Erlotinib
F - 23-19. ACDR to Immune Modulators
F - 23-2. Pustular Drug Eruption: Acute Generalized Exanthematous Pustulosis (AGEP)
F - 23-3. Pustular Drug Eruption: AGEP
F - 23-4. Pustular Drug Eruption: Erlotinib
F - 23-5. Drug-Induced Angioedema: Penicillin
F - 23-6. Fixed Drug Eruption
F - 23-7. Fixed Drug Eruption
F - 23-8. Drug Hypersensitivity Syndrome: Phenytoin
F - 23-9. Drug-Induced Pigmentation: Amiodarone
Fixed Drug Eruption
Pseudoporphyria
Pustular Eruptions
T - 23-1. Immunologically Mediated Adverse Cutaneous Drug Reactions
T - 23-2. Nonimmunologic Drug Reactions
T - 23-3. Types of Clinical ACDRs
T - 23-4. ACDR Mimicry of Other Dermatoses
T - 23-5. Drugs Causing Urticaria/Angioedema/Anaphylaxis
T - 23-6. Most Commonly Implicated Agents in Fixed Drug Eruptions
T - 23-7. Newer Chemotherapeutic Agents and Their ACDR
24. Disorders of Psychiatric Etiology
Body Dysmorphic Syndrome (BDS)
Cutaneous Signs of Injecting Drug Use
Delusions of Parasitosis
F - 24-1. Delusions of Parasitosis
F - 24-2. Neurotic Excoriations
F - 24-3. Neurotic Excoriations: Back
F - 24-4. Trichotillomania
F - 24-5. Factitious Syndrome
F - 24-6. Injecting Drug Use: Injection Tracks over Veins on the Lower Arms
F - 24-7. Linear Tattoos
F - 24-8. Injecting Drug Use: Cellulitis and Foreign-Body Response at Injection Site
Factitious Syndromes (Munchhausen Syndrome)
Neurotic Excoriations and Trichotillomania
III. Diseases Caused by Microbial Agents
25. Bacterial Colonizations and Infections of Skin and Soft Tissues
25. Bacterial Colonizations and Infections of Skin and Soft Tissues
Abscess, Folliculitis, Furuncle, and Carbuncle
Bacillary Angiomatosis (BA)
Bartonella Infections
Cat-Scratch Disease (CSD)
Cellulitis
Cutaneous Anthrax
Cutaneous Diphtheria
Cutaneous Nocardia Infections
Cutaneous Pseudomonas Aeruginosa Infections
Cutaneous Tuberculosis
Disorders Caused by Toxin-Producing Bacteria
Erythrasma
F - 25-1. Erythrasma: Groins
F - 25-10. Impetiginization of Contact Dermatitis: MRSA
F - 25-11. Secondary Infection of Mild Atopic Dermatitis: MRSA
F - 25-12. Bullous Impetigo
F - 25-13. Bullous Impetigo:
F - 25-14. Ecthyma: MSSA
F - 25-15. A-C Abscess: MSSA
F - 25-16. A, B Infectious Folliculitis, Superficial in Axilla: MRSA
F - 25-17. Infectious Folliculitis
F - 25-18. A, B: Infectious Folliculitis ('Hot Tub'):
F - 25-19. Furuncle: MSSA
F - 25-2. A, B Erythrasma: Webspace
F - 25-20. Furuncles and Cellulitis: MRSA
F - 25-21. Multiple Furuncles on the Lower Chest: MRSA
F - 25-22. Multiple Furuncles: MRSA
F - 25-23. Chronic Abscess, Botryomycosis: MRSA
F - 25-24. Carbuncle: MSSA
F - 25-25. Structural Components of the Skin and Soft Tissue, Superficial Infections, and Infections of the Deeper Structures
F - 25-26. Cellulitis at Portal of Entry: MSSA
F - 25-27. Cellulitis with Necrosis: MRSA
F - 25-28. Recurrent Cellulitis of the Arm with Chronic Lymphedema: MSSA
F - 25-29. Erysipelas of Thigh: Group B Streptococcus
F - 25-3. A, B Pitted Keratolysis: Plantar
F - 25-30. Erysipelas of Face: Group a Streptococcus
F - 25-31. Erysipeloid of Hand
F - 25-32. Ecthyma Gangrenosum
F - 25-33. Bilateral Cellulitis of Legs:
F - 25-34. Necrotizing Fasciitis of Lower Extremity
F - 25-35. Acute Lymphangitis of Forearm
F - 25-36. Laceration Infection in Renal Transplant Recipient: MRSA
F - 25-37. Surgical Excision Wound Infection: MSSA
F - 25-38. Burn Wound Infection: MSSA
F - 25-39. Wound Infection of Stasis Ulcer
F - 25-4. A, B Trichomycosis Axillaris
F - 25-40. Infection of Diabetic Ulcer: MRSA
F - 25-41. Wound Infection and Cellulitis: MRSA
F - 25-42. Staphylococcal Scalded-Skin Syndrome: Nikolsky Sign
F - 25-43. Staphylococcal Scalded-Skin Syndrome:
F - 25-44. Scarlet Fever: Exanthem
F - 25-45. Scarlet Fever: White and Red Strawberry Tongue
F - 25-46. A Cutaneous Anthrax
F - 25-47. Cutaneous Nocardiosis
F - 25-48. Chronic Cutaneous Nocardiasis
F - 25-49. African Spotted Fever:
F - 25-5. Intergluteal Intertrigo: Group a Streptococcus
F - 25-50. Rocky Mountain Spotted Fever: Early
F - 25-51. Rocky Mountain Spotted Fever: Early
F - 25-52. Rocky Mountain Spotted Fever: Late
F - 25-53. Rickettsialpox: Tache Noire
F - 25-54. Septic Vasculitis Associated with Bacteremia
F - 25-55. Infective Endocarditis, Acute: Janeway Lesions
F - 25-56. Infective Endocarditis, Acute: Subconjunctival Hemorrhage
F - 25-57. Septic Shock: Ischemic Necrosis of Acral Sites
F - 25-58. Acute Meningococcemia: Early Exanthem
F - 25-59. Acute Meningococcemia: Purpura Fulminans
F - 25-6. Erysipelas: Group G Streptococcus
F - 25-60. Bartonellosis: Cat-Scratch Disease with Primary Lesion
F - 25-61. Bartonellosis: Cat-Scratch Disease with Axillary Adenopathy
F - 25-62. Bartonellosis: Bacillary Angiomatosis
F - 25-63. Tularemia: Primary Lesion and Regional Adenopathy
F - 25-64. Leprosy: Tuberculoid Type
F - 25-65. Leprosy: Borderline-Type
F - 25-66. Diffuse Skin Infiltration, Multiple Nodular Lesions, and Sensory Loss are the Key Hallmarks of Lepromatous Leprosy (LL)
F - 25-67. Leprosy: Lepromatous Type
F - 25-68. Primary Inoculation Tuberculosis
F - 25-69. Tuberculosis Verrucosa Cutis
F - 25-7. A, B Webspace Intertrigo and Pseudomonal Toenail Infection:
F - 25-70. Lupus Vulgaris
F - 25-71. Scrofuloderma: Lateral Chest Wall
F - 25-72. Orificial Tuberculosis: Lips
F - 25-73. Purified Protein Derivative or Mantoux Test: Positive Test
F - 25-74. M. Marinum Inoculation Site Infection on the Foot
F - 25-75. M. Marinum Infection Verrucous Plaque
F - 25-76. M. Marinum Soft-Tissue Infection and Lymphangitis Beginning on Finger
F - 25-77. Buruli Ulcer
F - 25-78. M. Fortuitum Infection
F - 25-79. Multiple Sites of Soft-Tissue Infection Lower Leg:
F - 25-8. Impetigo: MSSA
F - 25-80. M. Chelonae Abscess on L-Dorsolateral Foot
F - 25-81. Lyme Borreliosis: Erythema Migrans (EM) on Upper Thigh
F - 25-82. Lyme Borreliosis: Erythema Migrans on Face
F - 25-83. Lyme Borreliosis: Lymphocytoma Cutis
F - 25-84. Lyme Borreliosis: Acrodermatitis Chronica Atrophicans: End Stage
F - 25-9. Impetigo: MSSA
Hansen Disease (Leprosy)
Impetigo
Infective Endocarditis
Intertrigo
Lyme Disease
Lymphangitis
Meningococcal Infection
Mycobacterial Infections
Mycobacterium Fortuitum Complex Infections
Mycobacterium Marinum Infection
Mycobacterium Ulcerans Infection
Necrotizing Soft-Tissue Infections
Nontuberculous Mycobacterial Infections
Pitted Keratolysis
Rickettsial Disorders
Rickettsialpox
Rocky Mountain Spotted Fever
Scarlet Fever
Sepsis
Soft-Tissue Infection
Staphylococcal Scalded-Skin Syndrome
Tick Spotted Fevers
Toxic Shock Syndrome
Trichomycosis
Tularemia
Wound Infection
26. Fungal Infections of the Skin, Hair, and Nails
26. Fungal Infections of the Skin, Hair, and Nails
Blastomycosis
Candidiasis
Chronic Mucocutaneous Candidiasis
Coccidioidomycosis
Cryptococcosis
Cutaneous Candidiasis
Dermatophytoses
Dermatophytoses of Hair
Disseminated Candidiasis
F - 26-1. Candida Albicans:
F - 26-10. Candidiasis: Vulvitis and Intertrigo
F - 26-11. Candidiasis: Balanoposthitis
F - 26-12. Mucocutaneous Candidiasis
F - 26-13. Mucocutaneous Candidiasis
F - 26-14. Invasive Candidiasis with Candidemia
F - 26-15. Malassezia Furfur:
F - 26-16. Pityriasis Versicolor
F - 26-17. Pityriasis Versicolor:
F - 26-18. Pityriasis Versicolor: Chest, Neck, and Shoulders
F - 26-19. Pityriasis Versicolor: Back
F - 26-2. Cutaneous Candidiasis: Intertrigo
F - 26-20. Pityriasis Versicolor: Back
F - 26-21. Infectious Folliculitis:
F - 26-22. Tinea Nigra
F - 26-23. Epidermal Dermatophyte Infections
F - 26-24. Hair Follicle Dermatophyte Infections
F - 26-25. Dermatophytes: Koh Preparation
F - 26-26. Tinea Pedis and Onychomycosis in Father and Son
F - 26-27. Tinea Pedis: Interdigital Dry Type
F - 26-28. Tinea Pedis: Interdigital Macerated Type
F - 26-29. Tinea Pedis: Moccasin Type
F - 26-3. Cutaneous Candidiasis
F - 26-30. Tinea Pedis: Moccasin Type
F - 26-31. Tinea Pedis: Bullous Types
F - 26-32. Tinea Manuum
F - 26-33. Tinea Manuum, Tinea Pedis, and Onychomycosis
F - 26-34. Tinea Cruris (Inguinalis): Acute
F - 26-35. Tinea Cruris (Inguinalis): Subacute
F - 26-36. Tinea Cruris (Inguinalis): Chronic
F - 26-37. Tinea Corporis: Tinea Incognito
F - 26-38. Tinea Corporis
F - 26-39. Tinea Corporis
F - 26-4. Cutaneous Candidiasis: Interdigital Intertrigo
F - 26-40. Tinea Corporis: Inflammatory
F - 26-41. Dermatophytic Folliculitis:
F - 26-42. Tinea Facialis
F - 26-43. Tinea Facialis
F - 26-44. Dermatophytic Folliculitis
F - 26-45. Tinea Capitis: 'Gray Patch' Type
F - 26-46. Tinea Capitis: 'Black Dot' Variant
F - 26-47. Kerion
F - 26-48. Tinea Capitis: Favus
F - 26-49. Tinea Barbae
F - 26-5. Candidiasis: Diaper Dermatitis
F - 26-50. Tinea Barbae with Kerion and Tinea Facialis
F - 26-51. Majocchi Granuloma
F - 26-52. Majocchi Granuloma
F - 26-53. Sporotrichosis: Nodular Lymphangitic Type
F - 26-54. Sporotrichosis: Chronic Lymphangitic Type
F - 26-55. Eumycetoma
F - 26-56. Chromoblastomycosis
F - 26-57. Cryptococcosis: Disseminated
F - 26-58. Histoplasmosis, Disseminated to Skin
F - 26-59. Histoplasmosis, Disseminated to Skin
F - 26-6. Oral Candidiasis: Thrush
F - 26-60. North American Blastomycosis: Disseminated
F - 26-61. Coccidioidomycosis: Disseminated
F - 26-62. Penicilliosis in HIV Disease: Disseminated Skin Lesions
F - 26-7. Oral Candidiasis: Thrush
F - 26-8. Oral Candidiasis: Atrophic and Pseudomembranous
F - 26-9. A, B: Angular Cheilitis
Genital Candidiasis
Histoplasmosis
Majocchi Granuloma
Oropharyngeal Candidiasis
Penicilliosis
Phaeohyphomycoses
Sporotrichosis
Subcutaneous Mycoses - Invasive and Disseminated Fungal Infections
Superficial Fungal Infections
Tinea Barbae
Tinea Capitis
Tinea Corporis
Tinea Cruris
Tinea Facialis
Tinea Incognito
Tinea Manuum CD-10: B35.2
Tinea Nigra
Tinea Pedis
Tinea Versicolor
Trichosporon Infections
27. Viral Diseases of Skin and Mucosa
27. Viral Diseases of Skin and Mucosa
Acute HIV Syndrome
Adverse Cutaneous Drug Eruptions in HIV Disease
Arbovirus
Chikungunya
Dengue
Eczema Herpeticum
Enteroviral Infections
Eosinophilic Folliculitis
Erythema Infectiosum
F - 27-1. Molluscum Contagiosum
F - 27-10. Verruca Vulgaris on Face
F - 27-11. Verruca Vulgaris: Fingers
F - 27-12. Verruca Vulgaris: Hands
F - 27-13. Periungual Warts
F - 27-14. Giant Warts on Hand and Forearm
F - 27-15. Verruca Plantaris: Plantar Foot
F - 27-16. Extensive Verrucae
F - 27-17. Verrucae Planae
F - 27-18. Filiform and Flat Warts
F - 27-19. Epidermodysplasia Verruciformis on Face
F - 27-2. Molluscum Contagiosum: Face
F - 27-20. Multiple Oral Condylomata
F - 27-21. Measles-Like Exanthema
F - 27-22. A, B Rubella
F - 27-23. Measles with Exanthem
F - 27-24. Hand-Foot-and-Mouth Disease
F - 27-25. Hand-Foot-and-Mouth Disease
F - 27-26. Herpangina
F - 27-27. Erythema Infectiosum: Slapped Cheek
F - 27-28. Gianotti-Crosti Syndrome
F - 27-29. Dengue Hemorrhagic Fever
F - 27-3. Molluscum Contagiosum: Penis
F - 27-30. Herpes Simplex: Typical Lesion
F - 27-31. Herpes Labialis
F - 27-32. Herpes Simplex Virus: Positive Tzanck Smear
F - 27-33. Herpes Simplex: Primary Infection of the Palm
F - 27-34. Herpes Simplex: Primary Infection with Gingivostomatitis
F - 27-35. Herpes Labialis: Recurrent Herpes Labialis
F - 27-36. Infectious Folliculitis: Herpes Simplex Virus
F - 27-37. Herpes Simplex Virus Infection: Herpetic Whitlow
F - 27-38. Herpes Simplex Virus Infection: Recurrent Erythema Multiforme
F - 27-39. Herpes Simplex in Neonate
F - 27-4. Molluscum Contagiosum: Face
F - 27-40. Herpes Simplex Virus Infection: Neonatal
F - 27-41. Herpes Simplex: Eczema Herpeticum
F - 27-42. Herpes Simplex: Extensive Eczema Herpeticum
F - 27-43. Herpes Simplex: Primary Infection in HIV Disease
F - 27-44. A 52-Year-Old Man with Advanced HIV Disease Had Chronic Herpetic Ulcers on Nares, Finger, and
F - 27-45. Herpes Simplex: Chronic Aggressive Herpetic Ulcers
F - 27-46. Disseminated Herpes Simplex 60-Year-Old Man with Lymphoma
F - 27-47. Varicella
F - 27-48. A-D Varicella
F - 27-49. Varicella and Herpes Zoster
F - 27-5. Human Orf: Multiple Lesions on Hands
F - 27-50. Dermatomes
F - 27-51. Herpes Zoster
F - 27-52. Herpes Zoster
F - 27-53. Herpes Zoster Cervical Distribution
F - 27-54. A-C Herpes Zoster: Atrophic and Hypopigmented Scars
F - 27-55. VZV: Necrotizing Herpes Zoster
F - 27-56. C-5-6 Zoster on the Shoulder of a 5-Year-Old Boy
F - 27-57. Varicella Zoster Virus Infection: Disseminated Cutaneous, in an Immunocompromised Patient
F - 27-58. VZV: Chronic Zoster in HIV Disease
F - 27-59. Exanthema Subitum
F - 27-6. Human Orf: Finger
F - 27-60. Acute HIV Syndrome: Exanthem
F - 27-61. Eosinophilic Folliculitis
F - 27-62. Eosinophilic Folliculitis
F - 27-63. Papular Pruritic Eruption of HIV Disease
F - 27-64. Lichenoid Photosensitive Eruption
F - 27-65. Hairy Leukoplakia
F - 27-66. Lipohypertrophy
F - 27-67. Lipoatrophy
F - 27-68. Squamous Cell Carcinoma in Situ
F - 27-7. Milker's Nodule: Finger
F - 27-8. Smallpox: Variola Major
F - 27-9. Smallpox: Scarring on Face
Gianotti-Crosti Syndrome
Hand Foot and Mouth Disease
Herpangina
Herpes Simplex Virus Disease
Herpes Simplex with Host Defense Defects
Human Herpesvirus -6 and -7 Disease
Human Immunodeficiency Virus Disease
Human Orf
Human Papillomavirus Infections
Human Papillomavirus: Cutaneous Diseases
Measles
Milker's Nodules
Molluscum Contagiosum
Neonatal Herpes Simplex
Nongenital Herpes Simplex
Oral Hairy Leukoplakia
Papular Pruritic Eruption of HIV
Photosensitivity in HIV Disease
Poxvirus Diseases
Rubella
Smallpox
Systemic Infections with Exanthems
T - 27-1. Correlation of Human Papillomavirus Type with Disease
Variations in Common Mucocutaneous Disorders in HIV Disease
Varicella Zoster Virus Disease
VZV: Herpes Zoster
VZV: Host Defense Defects
VZV: Varicella
Zika
28. Arthropod Bites, Stings, and Cutaneous Infestations
Cnidaria Envenomations
Cutaneous Larva Migrans
Cutaneous Reactions to Arthropod Bites
Demodicidosis
F - 28-1. Comparison of Blacklegged, Lone Star, and Dog Ticks
F - 28-10. Pediculosis Corporis
F - 28-11. Crab Louse
F - 28-12. Crab Louse
F - 28-13. Crab Lice in Eyelashes
F - 28-14. Crab Lice Infestation: Papular Urticaria
F - 28-15. Demodicidosis
F - 28-16. Burrow with Sarcoptes Scabiei (Female), Eggs, and Feces
F - 28-17. (A, B) Scabies with Burrows
F - 28-18. (A, B)Burrows of Scabies on the Palm and Wrist of a 3-Year-Old Boy
F - 28-19. (A,B) Burrows on Penis Shaft, Scrotum, and Groin
F - 28-2. Papular Urticaria
F - 28-20. Scabies: Predilection Sites
F - 28-21. Scabies with Nodules
F - 28-22. Scabies with Nodules
F - 28-23. (A-D) Crusted Scabies
F - 28-24. Scabies with Hyperinfestation
F - 28-25. (A, B) Cutaneous Larva Migrans
F - 28-26. Cutaneous Larva Migrans
F - 28-27. Larva Currens
F - 28-28. Schistosome Cercarial Dermatitis
F - 28-29. Seabather's Eruption
F - 28-3. Papular Urticaria
F - 28-30. Jellyfish Envenomation
F - 28-31. Fire Coral Envenomation
F - 28-4. Bullous Insect Bite
F - 28-5. Furuncular Myiasis
F - 28-6. Wound Myiasis
F - 28-7. (A, B) Tungiasis
F - 28-8. Immunologic IgE-Mediated Contact Urticaria: Pine Processionary Caterpillar
F - 28-9. Pediculosis Capitis: Nits
Pediculosis Capitis
Pediculosis Corporis
Pediculosis Pubis
Scabies
Schistosome Cercarial Dermatitis
Seabather's Eruption
Water-Associated Diseases
29. Systemic Parasitic Infections
Cutaneous Amebiasis
F - 29-1. A, B) New World Cutaneous Leishmaniasis: Ulcer on Thigh
F - 29-2. New World Cutaneous Leishmaniasis: Chiclero Ulcer
F - 29-3. Mucocutaneous Leishmaniasis: Espundia
F - 29-4. Old World Cutaneous Leishmaniasis: Face
F - 29-5. Old World Cutaneous Leishmaniasis
F - 29-6. Indian Post-Kala-Azar Dermal Leishmaniasis
F - 29-7. Human East African Trypanosomiasis: Trypanosomal Chancre
F - 29-8. Perianal Ulcer in a 35-Year-Old Man, 4 Weeks after Removal of Condylomata Acuminata by Electrodesiccation
Human African Trypanosomiasis
Human American Trypanosomiasis
Leishmaniasis
30. Sexually Transmitted Diseases
Chancroid
Congenital Syphilis
Donovanosis
F - 30-1. Papular Warts: Penis
F - 30-10. HPV Squamous Cell Carcinoma in Situ
F - 30-11. HPV-Induced in Situ and Invasive Squamous Cell Carcinoma: Vulva
F - 30-12. HPV-Induced in Situ and Invasive Squamous Cell Carcinoma: Perineal/Perianal
F - 30-13. Metastatic SCC of Urethra
F - 30-14. Genital Herpes, Primary
F - 30-15. (A,B) Genital Herpes, Primary
F - 30-16. Genital Herpes, Recurrent
F - 30-17. Genital Herpes, Recurrent: Vulva
F - 30-18. Genital Herpes, Recurrent
F - 30-19. Chronic Herpetic Ulcers
F - 30-2. Condyloma Acuminata
F - 30-20. Genital Herpes, Recurrent
F - 30-21. Neisseria Gonorrhoeae: Gram Stain
F - 30-22. Gonorrhea
F - 30-23. Disseminated Gonococcal Infection
F - 30-24. Primary Syphilis: Penile Chancre
F - 30-25. Primary Syphilis: Nodule on Glans
F - 30-26. Primary Syphilis: Chancre on Tip of the Tongue
F - 30-27. Secondary Syphilis
F - 30-28. (A,B) Secondary Syphilis
F - 30-29. Secondary Syphilis
F - 30-3. Condylomata Acuminata: Penis
F - 30-30. Secondary Syphilis: Papulosquamous Lesion
F - 30-31. Secondary Syphilis: Papulosquamous Lesions
F - 30-32. Secondary Syphilis: Annular Facial Lesions
F - 30-33. Secondary Syphilis: Condylomata Lata
F - 30-34. Tertiary Syphilis
F - 30-35. Lymphogranuloma Venereum: Groove Sign
F - 30-36. Chancroid
F - 30-37. Chancroid
F - 30-38. Donovanosis: Ulcerovegetative Type
F - 30-4. Condylomata Acuminata: Vulva
F - 30-5. (A,B) Genital Warts
F - 30-6. Keratotic External Genital Warts (EGW): Male
F - 30-7. Condylomata Acuminata: Uterine Cervix
F - 30-8. HPV Squamous Cell Carcinoma in Situ
F - 30-9. HPV Squamous Cell Carcinoma in Situ
Genital Warts
Herpes Simplex Virus: Genital Disease
HPV: Squamous Cell Carcinoma in Situ (SCCIS) and Invasive SCC of Anogenital Skin
Human Papillomavirus: Anogenital Infections
Latent Syphilis
Lymphogranuloma Venereum
Neisseria Gonorrhoeae Disease
Neisseria Gonorrhoeae: Gonorrhea
Primary Syphilis
Secondary Syphilis
Syphilis
Tertiary/Late Syphilis
IV. Skin Signs of Hair, Nail, and Mucosal Disorders
31. Disorders of Hair Follicles and Related Disorders
Alopecia Areata
Anagen Effluvium
Biology of Hair Growth Cycles
Cicatricial or Scarring Alopecia
Excess Hair Growth
F - 31-1. Hair Growth Cycle
F - 31-10. Alopecia Areata Universalis (AAU)
F - 31-11. Telogen Effluvium
F - 31-12. Anagen Effluvium: Chemotherapy
F - 31-13. Scarring Alopecia of Scalp: Chronic Cutaneous Lupus Erythematosus (CCLE)
F - 31-14. Diffuse and Scarring Alopecia of Scalp: Systemic LE (SLE) and CCLE Lesions
F - 31-15. Scarring Lesions at Multiple Stages of Evolution
F - 31-16. Scarring Alopecia of Scalp: Pseudopelade of Brocq Caused by Lichen Planus
F - 31-17. Scarring Alopecia of Scalp: Lichen Planopilaris (LPP)
F - 31-18. Scarring Alopecia of Scalp: Pseudopelade of Brocq
F - 31-19. Scarring Alopecia of Scalp: Folliculitis Decalvans
F - 31-2. Hair Mount
F - 31-20. Scarring Alopecia of Scalp: Dissecting Folliculitis
F - 31-21. Scarring Alopecia of Scalp: Folliculitis Keloidalis
F - 31-22. Pseudofolliculitis Barbae
F - 31-23. Hirsutism: Face and Chest
F - 31-24. Hypertrichosis of Face
F - 31-3. Androgenetic Alopecia: Patterns in Men and Women
F - 31-4. Pattern Hair Loss: Male, Hamilton Type III
F - 31-5. Pattern Hair Loss: Male, Hamilton Types IV to V
F - 31-6. Pattern Hair Loss: Female, Ludwig Type II
F - 31-7. Pattern Hair Loss: Female, Temporal Recession
F - 31-8. Alopecia Areata (AA) of Scalp: Solitary Lesion
F - 31-9. Alopecia Areata of Scalp: Multiple, Lesions
Hair Loss: Alopecia
Hirsutism
Hypertrichosis
Pattern Hair Loss
T - 31-1. Etiology of Hair Loss
T - 31-2. Drug-Induced Alopecia
T - 31-3. Classification of Primary Cicatricial Alopecias
T - 31-4. Etiology of Hirsutism
Telogen Effluvium
32. Disorders of the Nail Apparatus
Acrolentiginous Melanoma (ALM)
Acute Paronychia
Alopecia Areata (AA)
Candida Onychomycosis
Clubbed Nails
Components of the Normal Nail Apparatus
Darier Disease (Darier-White Disease, Keratosis Follicularis)
Digital Mucous Cyst
Drug-Induced Nail Changes
F - 32-1. Schematic Drawing of Normal Nail
F - 32-10. Alopecia Areata: Trachonychia
F - 32-11. Darier Disease
F - 32-12. Myxoid Cysts
F - 32-13. Junctional Nevomelanocytic Nevus of the Nail Matrix
F - 32-14. Acrolentiginous Melanoma Versus Subungual Hemorrhage
F - 32-15. HPV-Induced in Situ and Invasive Squamous Cell Carcinoma
F - 32-16. Acute Paronychia
F - 32-17. Felon
F - 32-18. Candida Onychomycosis: Total Dystrophic Type
F - 32-19. Onychomycosis of Toenails: Distal and Lateral Subungual Type (DLSO)
F - 32-2. Chronic Paronychia
F - 32-20. Superficial White Onychomycosis (SWO)
F - 32-21. Proximal Subungual Onychomycosis Type (PSO)
F - 32-22. Cancer Chemotherapy: Beau Lines
F - 32-23. Apparent Leukonychia: Terry's Nails
F - 32-24. Yellow Nail Syndrome
F - 32-25. Tuberous Sclerosis: Periungual Fibroma
F - 32-26. Infective Endocarditis: Splinter Hemorrhage
F - 32-27. Systemic Lupus Erythematosus: Nail Fold Erythema and Telangiectasia
F - 32-28. Discoid Lupus Erythematosus: Nail Fold and Matrix Involvement and Nail Dystrophy
F - 32-29. Systemic Amyloidosis
F - 32-3. Onycholysis
F - 32-30. Koilonychia
F - 32-31. Lung Cancer: Clubbed Fingers
F - 32-32. Nail Discoloration: Quinacrine
F - 32-33. Nail Discoloration and Transverse Bands (Muehrcke Lines)
F - 32-34. Nail Discoloration: Argyria
F - 32-4. Onycholysis with Pseudomonas Colonization
F - 32-5. Onychauxis and Onychogryphosis
F - 32-6. Habit-Tic Deformity
F - 32-7. Compulsive Nail Picking
F - 32-8. Psoriasis Vulgaris
F - 32-9. Lichen Planus
Felon
Infections of the Nail Apparatus
Koilonychia
Leukonychia
Lichen Planus - Section 32
Lichen Planus (LP)
Local Disorders of Nail Apparatus
Longitudinal Melanonychia
Nail Fold/Periungual Erythema and Telangiectasia
Neoplasms of the Nail Apparatus
Normal Nail Apparatus
Onychauxis and Onychogryphosis
Onycholysis
Onychomycosis
Onychotillomania
Paronychia
Periungual Fibroma
Psoriasis - Nail Involvement of Cutaneous Diseases
Splinter Hemorrhages
Squamous Cell Carcinoma
T - 32-1. Management of Tinea Unguium
Transverse Grooves (Beau Lines) - Nail Signs of Multisystem Diseases ICD-10: L60.0
Yellow Nail Syndrome
33. Disorders of the Mouth
Actinic Cheilitis
Acute Necrotizing Ulcerative Gingivitis
Angular Cheilitis (Perleche) - Diseases of the Lips ICD-10: K13.0
Aphthous Ulceration
Black or White Hairy Tongue
Bullous Pemphigoid
Cutaneous Disorders Involving the Mouth
Cutaneous Odontogenic (Dental) Abscess
Dysplasia and Squamous Cell Carcinoma in Situ (SCCIS) - Premalignant and Malignant Neoplasms ICD-10: C14
F - 33-1. Angular Cheilitis
F - 33-10. Aphthous Ulcers: Minor
F - 33-11. Aphthous Ulcers: Major
F - 33-12. Leukoedema
F - 33-13. (A, B) Lichen Simplex Chronicus
F - 33-14. Chronic Chewing
F - 33-15. Nicotine Stomatitis
F - 33-16. Condyloma Acuminatum: Mucosal Lip
F - 33-17. Squamous Cell Carcinoma in Situ: Inferolateral Tongue
F - 33-18. Invasive Squamous Cell Carcinoma: Palate
F - 33-19. Verrucous Carcinoma: Buccal Mucosa
F - 33-2. Fissured Tongue
F - 33-20. Melanoma: Hard Palate
F - 33-21. Mucocele
F - 33-22. Irritation Fibroma: Lower Lip
F - 33-23. Cutaneous Odontogenic Abscess: Cheek
F - 33-24. Pemphigus Vulgaris
F - 33-25. Paraneoplastic Pemphigus
F - 33-26. Bullous Pemphigoid
F - 33-27. Mucous Membrane Pemphigoid
F - 33-28. Lupus Erythematosus: Hard Palate
F - 33-29. Toxic Epidermal Necrolysis
F - 33-3. Hairy Tongue
F - 33-4. Migratory Glossitis
F - 33-5. Torus Palatinus
F - 33-6. Lichen Planus: Wickham Striae
F - 33-7. Lichen Planus: Desquamative Gingivitis
F - 33-8. Acute Necrotizing Ulcerative Gingivitis (ANUG)
F - 33-9. Gingival Hyperplasia: Acute Monocytic Leukemia
Fissured Tongue - Conditions of the Tongue, Palate, and Mandible ICD-10: K14
Gingival Hyperplasia
Gingivitis and Periodontitis - Diseases of the Gingiva, Periodontium, and Mucous Membranes ICD-10: K06
Irritation Fibroma
Leukoplakia
Lichen Planus - Section 33
Lupus Erythematosus
Migratory Glossitis
Mucocele - Submucosal Nodules
Mucous Membrane Pemphigoid
Oral Hairy Leukoplakia
Oral Invasive Squamous Cell Carcinoma
Oral Verrucous Carcinoma
Oropharyngeal Melanoma
Palate and Mandibular Torus
Paraneoplastic Pemphigus
Pemphigus Vulgaris (PV)
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
Systemic Diseases Involving the Mouth
T - 33-1. Differential Diagnosis of Leukoplakia
34. Disorders of the Genitalia, Perineum, and Anus
34. Disorders of the Genitalia, Perineum, and Anus
Allergic Contact Dermatitis - Eczematous Dermatitis
Angiokeratoma
Anogenital Infections
Atopic Dermatitis, Lichen Simplex Chronicus, Pruritus Ani
Extramammary Paget Disease
F - 34-1. Pearly Penile Papules
F - 34-10. A, B Psoriasis Vulgaris: Penis
F - 34-11. Psoriasis Vulgaris: Intertriginous
F - 34-12. Lichen Planus, Annular: Penis
F - 34-13. Lichen Planus, Erosive: Penis
F - 34-14. Lichen Nitidus: Penis
F - 34-15. Lichen Sclerosus: Penis
F - 34-16. Lichen Sclerosus: Vulva and Perineum
F - 34-17. Lichen Sclerosus: Penis
F - 34-18. Allergic Contact Dermatitis: Penis
F - 34-19. Lichen Simplex Chronicus: Scrotum
F - 34-2. Sclerosing Lymphangitis: Penis
F - 34-20. Lichen Simplex Chronicus: Pruritus Ani
F - 34-21. Fixed Drug Eruption: Trimethoprim-Sulfamethoxazole
F - 34-22. Squamous Cell Carcinoma in-Situ (SCCIS)
F - 34-23. HPV-Induced Squamous Cell Carcinoma in Situ: Perianal
F - 34-24. Squamous Cell Carcinoma in Situ Arising in Lichen Sclerosus: Vulva
F - 34-25. HPV-Induced Invasive Squamous Cell Carcinoma: Perineum
F - 34-26. Melanoma, Invasive: Penis
F - 34-27. Melanoma, Invasive: Vulva
F - 34-28. Extramammary Paget Disease:
F - 34-29. Kaposi Sarcoma: Penis
F - 34-3. Chronic Lymphedema:
F - 34-4. A, B Plasma Cell Balanitis
F - 34-5. Phimosis
F - 34-6. Paraphimosis
F - 34-7. Genital Lentiginoses: Vulva
F - 34-8. Genital Lentiginoses: Penis
F - 34-9. Vitiligo: Penis
Fixed Drug Eruption
Genital (Penile/Vulvar/Anal) Lentiginoses - Mucocutaneous Disorders
Genital Aphthous Ulcerations
Genital Verrucous Carcinoma
HPV-Induced Intraepithelial Neoplasia (in) and Squamous Cell Carcinoma in Situ
Invasive SCC of Cutaneous Anus
Invasive SCC of Penis - Invasive Anogenital Squamous Cell Carcinoma
Invasive SCC of Vulva
Kaposi Sarcoma
Lichen Nitidus
Lichen Planus
Lichen Sclerosus
Lymphedema of the Genitalia
Malignant Melanoma of the Anogenital Region
Migratory Necrolytic Erythema
Pearly Penile Papules
Phimosis, Paraphimosis, Balanitis Xerotica Obliterans
Plasma Cell Balanitis and Vulvitis
Psoriasis Vulgaris
Sclerosing Lymphangitis of Penis
Sebaceous Gland Prominence
Squamous Cell Carcinoma (SCC) in Situ (SCCIS) - Premalignant and Malignant Lesions
Vitiligo and Leukoderma
35. Generalized Pruritus Without Skin Lesions (Pruritus Sine Materia)
35. Generalized Pruritus Without Skin Lesions (Pruritus Sine Materia)
F - 35-1. Pruritus Without Diagnostic Skin Lesions
F - 35-2. Notalgia Paresthetica
Most Important Causes
T - 35-1. Causes of Pruritus Sine Materia
T - 35-2. Approach to the Diagnosis of Generalized Pruritus Without Diagnostic Skin Lesions
Appendices
A. Differential Diagnosis of Pigmented Lesions
A. Differential Diagnosis of Pigmented Lesions
F - A-1. Common Pigmented Lesions Encountered in Primary Care Medicine
F - A-10. Dermatofibroma
F - A-11. Pyogenic Granuloma
F - A-12. Venous Lake
F - A-13. Talon Noir
F - A-14. Dermatosis Papulosa Nigra
F - A-2. Melanocytic Nevus
F - A-3. Dysplastic Nevus
F - A-4. Blue Nevus
F - A-5. Solar Lentigo
F - A-6. (A and B) Melanoma
F - A-7. Seborrheic Keratosis
F - A-8. Angiokeratoma
F - A-9. Pigmented Basal Cell Carcinoma
B. Dermoscopy
B. Dermoscopy
F - B-1. Blue Nevus with Homogeneous Steel-Blue Pigmentation
F - B-10. Nodular Basal Cell Carcinoma with Arborizing Vessels
F - B-2. Benign Nevus Demonstrating a Regular, Symmetrical Reticular Network
F - B-3. Benign Nevus with a Cobblestone Globular Pattern
F - B-4. Melanoma with Atypical Pigment Network, Regression, and Crystalline Structures
F - B-5. Melanoma with Negative Network, Atypical Pigment Network, Asymmetric Aggregated Globules, and Off-Center Blotches of Pigment
F - B-6. Angioma with Homogeneous Purple Lacunae Separated by White Septae
F - B-7. Dermatofibroma with Delicate Peripheral Reticular Network Surrounding a Prominent Central Scar-Like Area
F - B-8. Scabies Delta-Wing Sign Representing a Burrow
F - B-9. Seborrheic Keratosis with Comedo-Like Openings and Pseudohorn Cysts Under Nonpolarized Dermoscopy
T - B-1. Dermoscopic Features of Benign and Malignant Melanocytic Lesions
T - B-2. Dermoscopic Features of Benign and Malignant Nonmelanocytic Lesions
C. Drug Use in Pregnancy
C. Drug Use in Pregnancy
T - C-1. Safe Treatments for Dermatologic Disorders During Pregnancy
T - C-2. Current FDA Categorization for Drugs Used During Pregnancy and Breastfeeding
Front Matter
Acknowledgments
How to Use This Book
F - I-1. Macule
F - I-10. Erosion
F - I-11. Ulcer
F - I-12. Scar
F - I-13. Atrophy
F - I-14. Cyst
F - I-2. Papule
F - I-3. Plaque
F - I-4. Nodule
F - I-5. Wheal
F - I-6. Vesicle
F - I-7. Pustule
F - I-8. Crust
F - I-9. Scale
How to Use This Book
T - I-1. Algorithm for Evaluating Skin Lesions
Preface
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
GoogleAnalytics
Newer Chemotherapeutic Agents and Their ACDR
i
GoogleAnalytics
Topic is locked.
Purchase entire reference Mobile/Web for $71.99
PURCHASE NOW
Already Purchased?
Sign In
;
